The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free circulating tumor DNA somatic alteration burden and its impact on survival in metastatic cancer.
 
Seyed Saeed Pairawan
No Relationships to Disclose
 
Kenneth R. Hess
No Relationships to Disclose
 
Filip Janku
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; Immunome; Novartis; Sequenom; Trovagene
Research Funding - Agios; Astellas Pharma; BioMed Valley Discoveries; Deciphera; Fujifilm; Novartis; Piqur; Plexxikon; Roche; Symphony Evolution
Other Relationship - Bio-Rad
 
Nora Sylvia Sanchez
No Relationships to Disclose
 
Cathy Eng
Honoraria - Bayer; Celgene; Roche; Sirtex Medical
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Advaxis; Forty Seven; Genentech/Roche; Keryx
Travel, Accommodations, Expenses - Bayer; Genentech/Roche; Sirtex Medical
 
Senthil Damodaran
No Relationships to Disclose
 
Milind M. Javle
No Relationships to Disclose
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Research Funding - Bayer/Onyx; Bristol-Myers Squibb; Genentech; Merck
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb; Exelixis; Merck
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena
Honoraria - Adaptimmune; Baxter; Bayer; Merrimack
Consulting or Advisory Role - Baxter; Bayer; Guidepoint Global; Janssen
Research Funding - Abbvie; Adaptimmune; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Genentech; Genmab; Ignyta; Infinity Pharmaceuticals; Kite, a Gilead company; Kyowa Hakko Kirin; Lilly; Loxo; MedImmune; Merck; Mirati Therapeutics; miRNA Therapeutics; Molecular Templates; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
Other Relationship - Oncorena
 
Vivek Subbiah
Consulting or Advisory Role - MedImmune
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; PharmaMar
 
Siqing Fu
No Relationships to Disclose
 
David R. Fogelman
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Victoria M. Raymond
Employment - Guardant Health; Trovagene
Stock and Other Ownership Interests - Guardant Health; Trovagene
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Biolase; Guardant Health
Stock and Other Ownership Interests - Biolase; Guardant Health
Research Funding - Guardant Health
 
Funda Meric-Bernstam
Honoraria - Dialectica; Sumitomo Group
Consulting or Advisory Role - Clearlight Diagnostics; DarwinHealth; Genentech; GRAIL; Inflection Biosciences; Pieris Pharmaceuticals; Samsung Bioepis
Research Funding - Abbvie; Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; Curis; CytomX Therapeutics; Debiopharm Group; eFFECTOR Therapeutics; Genentech; Jounce Therapeutics; Novartis; Pfizer; PUMA Biotechnology; Taiho Pharmaceutical; Zymeworks